Multiple studies have shown that vWF is not expressed by LSECs in healthy livers but is increased in LSECs during fibrosis in several animal models, for example after CCl4 treatment in mice and rats (60, 61), and NASH with or without cirrhosis in rats (62). The gene discussed is VWF; the disease is metabolic dysfunction-associated steatohepatitis.